Workflow
佳兆业健康(00876) - 2021 - 年度财报
KAISA HEALTHKAISA HEALTH(HK:00876)2022-04-29 08:39

Financial Performance - The company recorded revenue of approximately HKD 209.6 million for the year ended December 31, 2021, representing a 14.04% increase from HKD 183.8 million in 2020[5] - The net profit attributable to shareholders was HKD 2.4 million, a significant recovery from a loss of HKD 39.7 million in the previous year[5] - The group's revenue for the year reached approximately HKD 209.6 million, an increase of 14.04% compared to HKD 183.8 million in the previous year[20] - The net profit attributable to shareholders was approximately HKD 2.4 million, with basic earnings per share of HKD 0.05, a recovery from a loss of HKD 39.7 million and basic loss per share of HKD 0.79 in the previous year[20] - The company's gross profit for the year was HKD 97.4 million, an increase of approximately HKD 7.4 million from the previous year, with a gross margin of 46.5%[41] Business Expansion and Acquisitions - The company acquired 100% of Basic Dental, which owns the BIOTANIUM dental implant brand, enhancing its product offerings in the dental sector[7] - The group acquired 100% of Basic Dental Implant System, Inc., entering the high-value dental implant market, which has significant growth potential[24] - The company anticipates that the Shili Lianjiang project will contribute approximately RMB 250 million in contract sales starting in 2022[12] - The company plans to expand its rehabilitation services in Shenzhen and potentially extend these services to other core cities in the Greater Bay Area[14] - The company aims to enhance its dental business by expanding its sales network domestically and internationally, particularly in the U.S.[11] Research and Development - Research and development expenditure decreased to HKD 17.2 million from HKD 20.4 million, reflecting the management's commitment to investing in future technologies[24] - The company plans to establish a new high-tech enterprise focused on implant technology development within three years to enhance domestic product offerings[35] - The company aims to enhance R&D investment and innovation, introducing high-value-added products to meet the growing demand in dental healthcare and rehabilitation[183] Financial Position and Assets - The cash balance as of December 31, 2021, was approximately HKD 259.3 million, up from HKD 176.6 million in the previous year[50] - As of December 31, 2021, the equity attributable to shareholders was approximately HKD 651,100,000, an increase from HKD 636,500,000 in 2020[54] - The net current assets as of December 31, 2021, were approximately HKD 313,800,000, up from HKD 239,600,000 in 2020, with current and quick ratios of 2.20 and 2.14 respectively[54] - The company had no debt net amount as of December 31, 2021, indicating no capital debt ratio calculation[54] Operational Developments - The group generated revenue of approximately RMB 3.72 million (around HKD 4.49 million) from the first sports rehabilitation clinic, and RMB 1.66 million (around HKD 2 million) from the second clinic[28] - The group invested a total of RMB 180 million (approximately HKD 220.4 million) in limited partnership investments, focusing on information technology and quality healthcare sectors[31] - The group is actively exploring the "agriculture (culture) tourism + health" model in the Zhuhai project, which is currently under orderly construction[27] Corporate Governance - The board believes effective corporate governance is crucial for maintaining development and enhancing shareholder value[93] - The company has complied with the new corporate governance code effective from January 1, 2022, with some exceptions noted[93] - The board consists of a balanced mix of executive and independent non-executive directors, ensuring compliance with listing rules[101] - The company has established three committees: the nomination committee, remuneration committee, and audit committee, each with defined terms of reference[130] Risk Management and Compliance - The company has established multiple risk management procedures and guidelines, with the board conducting an annual review of the effectiveness of the risk management and internal control systems[146] - The internal control review indicated that significant risks threatening the achievement of business objectives have been identified and assessed[146] - The company has implemented policies for the handling and disclosure of inside information to ensure compliance with securities regulations[148] Environmental, Social, and Governance (ESG) - The ESG report aims to transparently disclose the group's performance in environmental, social, and governance aspects over the past year[172] - The company aims to integrate sustainability into its dental and health business development, recognizing the importance of ESG strategies in decision-making[181] - The company emphasizes energy conservation, greenhouse gas reduction, and providing a safe and healthy work environment for employees as part of its corporate social responsibility[185] - The company has established a comprehensive ESG framework, with various departments responsible for implementing ESG initiatives and evaluating reports[185] Employee and Stakeholder Engagement - The company conducted 67 meetings with approximately 1,067 employees during the reporting period[191] - A total of 400 interviews were held with 300 customers during the reporting period[192] - The company recognizes the importance of stakeholder communication and has set up various channels to address stakeholder feedback effectively[189]